Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2022 | Story Anthony Mthembu

According to the Gender Equality and Anti-Discrimination Office (GEADO) at the University of the Free State (UFS), an alarming number of transgender and gender-diverse persons at South African institutions of higher learning are consistently met with a great deal of neglect and exclusion. Therefore, it is imperative to constantly shine light on the injustice and violation of their human rights in order to enable spaces that acknowledge their lived realities and uphold their human dignity. 

The importance of the march

As such, the Gender Equality and Anti-Discrimination Office will be hosting a transgender march on the Bloemfontein Campus on 17  May 2022. 

“The aim of this march is to raise awareness about issues of transsexuality and gender-diverse individuals. We hope to accentuate the voices of transgender individuals and gender-diverse persons on our campuses,” expressed Delisile Mngadi, Assistant Officer in the Gender Equality and Anti-Discrimination Office. The march will commence at 09:30 from the Main Gate and will end at the Centenary Complex. In addition, members of the Gender Equality and Anti-Discrimination Office argue that the purpose of the march is to remind members of the UFS community and the society at large that the stories, the voices, and experiences of transgender and gender-diverse individuals do matter.

An invitation to staff and students 

Members of the UFS community, regardless of how they identify, are invited to take part in the march. “It is also important that cishetero persons attend the march; this shows that they stand in support of all gender-diverse persons, and it is also a great opportunity to learn.  Another reason why it is important for cisgender persons to attend the march is because violence and discrimination targeted at transgender persons remain a daily reality on our campuses, which inadvertently maintains heteronormative notions and patriarchal power that validates transphobia and homophobia,” Mngadi indicated. 

UFS staff and students who will be in attendance can expect to hear speeches from a few invited dignitaries. In addition, Mngadi, along with other members of the office, maintains that this is an opportunity for staff and students to engage with one another. The march is particularly important because it will teach staff and students “to be aware of the diversity that exists within our institution, a diversity that transcends language, religion, and ethnicity – to name just a few. People will also learn to respect this diversity, and most importantly, to understand that all lives matter”, said Mngadi.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept